Clinical Research Directory

Long-term Follow-up (LTFU) of Participants Who Received Azer-Cel

Sponsor: TG Therapeutics, Inc.

Summary

The main objective of this study is to collect data on the long-term safety of azer-cel, primarily through the capture of clinical events of interest (CEI) for up to 15 years following participation in TG-Azercel -101 study.

Official title: Long-term Follow-up (LTFU) of Study Participants Who Received Azer-Cel, An Allogeneic Chimeric Antigen Receptor T-Cell Product, in a TG Therapeutics, Inc., Clinical Study

Key Details

Conditions

Interventions

Locations (1)